Clinical Trial Update: Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic umbilical cord-derived hematopoietic and mesenchymal stem cells for cerebral palsy (spastic type).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Spastic Cerebral Palsy

Drugs mentioned

• Allogeneic umbilical cord-derived hematopoietic and mesenchymal stem cells

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cerebral Palsy, Spastic | Phase 2 | Status: UNKNOWN